Combined High-Intensity Aerobic Training and Resistance Training in Psoriatic Arthritis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorVastra Gotaland Region

About this trial

The goal of this randomised controlled trial is to evaluate the effects of a 12-week intervention comprising high-intensity interval aerobic training and strength training on cardiovascular function, metabolic health profile and inflammation in patients with Psoriatic arthritis. A secondary goal is to assess the intervention´s impact on physical fitness, pain, fatigue, and health-related quality of life, and to explore long-term maintenance of exercise following completion of the intervention. We hypothesize that 12 weeks of combined high-intensity interval aerobic training and strength training will improve cardiometabolic health, inflammation, and enhance physical fitness, fatigue, pain and quality of life in Psoriatic arthritis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Psoriatic arthritis disease according to the CASPAR (Classification Criteria for Psoriatic Arthritis) criteria

Age range 18-65 years

Stable medication on anti- rheumatic drugs for >3 months prior to inclusion and throughout the first 3 months of the study

Disqualifiers

Cardiovascular disease

Severe hypertension

Diabetes type I

Chronic obstructive pulmonary disease or other severe pulmonary diseases

Trial design

Design model

Parallel

Treatments tested in this trial

  • Exercise program

    Behavioral

    The exercise program includes two supervised sessions per week combining high-intensity interval training and strength training, plus one additional non-supervised aerobic session. The target of the high intensity intervals is 90%-95% of heart rate maximum. The strength training of major muscle groups includes 2-3 sets of 8-10 repetitions.

Treatment groups

88 Participants
are divided into 2 treatment groups
Group A: Exercise groupExperimental treatment 1 intervention
Group B: Control groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Cardiopulmonary function

Change in maximum oxygen uptake (VO2ml/min/kg). Higher value indicate better cardiorespiratory capacity.

Time frame
Baseline and 3 month
2

Cardiopulmonary function

Change in maximum oxygen uptake (VO2ml/min/kg). Higher value indicate better cardiorespiratory capacity)

Time frame
Baseline and 9 month

Secondary outcomes

1

Waist circumference

Change in waist circumference (cm) measured with a tape measure midway between the lower rib and iliac crest. A waist measurement of 80 centimeters or more for women and 94 centimeters or more for men indicate increased risk for diseases related to overweight.

Time frame
Baseline and 3 months
2

Waist circumference

Change in waist circumference (cm) measured with a tape measure midway between the lower rib and iliac crest. A waist measurement of 80 centimeters or more for women and 94 centimeters or more for men indicate increased risk for diseases related to overweight.

Time frame
Baseline and 9 months
3

Body mass index (BMI)

Change in Body Mass Index (BMI). Weight and height will be combined to report BMI (kg/m2). A higher score indicate higher relative weight.

Time frame
Baseline and 3 months
4

Body mass index (BMI)

Change in Body Mass Index (BMI). Weight and height will be combined to report BMI (kg/m2). A higher score indicate higher relative weight.

Time frame
Baseline and 9 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: